S’pore launches $130m RNA research programme to tackle a wider range of ailments
SINGAPORE – A new programme has launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine ...
Protecting crops: RNA-based substances open up new avenue to combat a widespread plant virus
New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...
RNA-editing protein insights could lead to improved treatment for cancer and autoimmune diseases
A research team led by Rice University's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a ...
Science Daily1d
Universal RNA barcoding system for tracking gene transfer in bacteria
In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive antibiotic resistance and even shape entire ecosystems. Now an interdisciplinary ...
Scientists Unveil a Game-Changing RNA Shield Against Crop Viruses
Researchers at Martin Luther University have developed groundbreaking RNA-based agents that offer high levels of protection ...
Scientists Discover How To Reactivate Cancer’s Dormant “Kill Switch”
The discovery could pave the way for a groundbreaking RNA-based multi-cancer treatment. Alternative RNA splicing functions ...
RNA origami technique folds nanotubes to create artificial cytoskeletons for synthetic cells
With the long-term goal of creating living cells from non-living components, scientists in the field of synthetic biology ...
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives $66.69 Average Target Price from Analysts
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the thirteen research ...
Knowridge Science Report12d
New RNA vaccine shows promise for pancreatic cancer treatment
A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...
The Manila Times2h
Ractigen's RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025
Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, today announced the presentation of positive preliminary data from its ongoing ...
IFLScience on MSN2d
New MERS-Related Coronavirus Discovered In Brazilian Bats – But Can It Infect Humans?
Since it was first identified in 2012, the World Health Organization (WHO) says there have been a total of 2,618 confirmed ...
Fierce Pharma3d
Alnylam's Amvuttra wins key approval in ATTR-CM, teeing up showdown with Pfizer
Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA interference approach can set it apart from its peers. | Despite growing competition ...